IA-0130, a novel 3-(1,3-diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL-6/gp130/STAT3 signalling. - Park SA; Kim HJ; Kim LK; Lee HR; Jung BK; Kim JH; Kim MJ; Oh TG; Kang HE; Shin KJ; Seo JH; Heo TH (British journal of pharmacology, 2025)